Effects of glycyrrhetinic acid and liquorice extract on cell proliferation and prostate-specific antigen secretion in LNCaP prostate cancer cells

被引:31
|
作者
Hawthorne, Susan [1 ]
Gallagher, Sandra [1 ]
机构
[1] Queens Univ Belfast, Ctr Med Biol, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland
关键词
D O I
10.1211/jpp.60.5.0013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glycyrrhetinic acid (GA) is the active metabolite of glycyrrhizic acid, one of the components of liquorice extract. It has been shown to possess anti-inflammatory activity and to inhibit hepatic tumour growth. In this preliminary study, we have shown that GA could significantly reduce the rate of proliferation of LNCaP androgen dependent prostate cancer cells, whereas it had no effect on proliferation of PC3 and DU145 androgen-independent prostate cancer cells. Additionally, GA could significantly reduce the production of prostate-specific antigen by LNCaP cells maintained in-vitro. This study provides a sound platform for further investigation.
引用
收藏
页码:661 / 666
页数:6
相关论文
共 50 条
  • [1] The biosynthesis and secretion of prostate-specific antigen in LNCaP cells
    Gau, JT
    Salter, RD
    Krill, D
    Grove, ML
    Becich, MJ
    CANCER RESEARCH, 1997, 57 (17) : 3830 - 3834
  • [2] Vasoactive intestinal peptide stimulates prostate-specific antigen secretion by LNCaP prostate cancer cells
    Gkonos, PJ
    Ashby, MH
    Andrade, AA
    REGULATORY PEPTIDES, 1996, 65 (02) : 153 - 157
  • [3] Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells
    Fujii, Y
    Kawakami, S
    Okada, Y
    Kageyama, Y
    Kihara, K
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2004, 286 (06): : E927 - E931
  • [4] Effects of 14 frequently used drugs on prostate-specific antigen expression in prostate cancer LNCaP cells
    Iguchi, Kazuhiro
    Hashimoto, Maki
    Kubota, Masafumi
    Yamashita, Shuji
    Nakamura, Mitsuhiro
    Usui, Shigeyuki
    Sugiyama, Tadashi
    Hirano, Kazuyuki
    ONCOLOGY LETTERS, 2014, 7 (05) : 1665 - 1668
  • [5] PROSTATE-SPECIFIC ANTIGEN AND PROSTATE-SPECIFIC ACID-PHOSPHATASE IN NEUROENDOCRINE CELLS OF PROSTATE-CANCER
    COHEN, RJ
    GLEZERSON, G
    HAFFEJEE, Z
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1992, 116 (01) : 65 - 66
  • [6] Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cells
    Shannon C. Dixon
    Erwin A. Kruger
    Ken S. Bauer
    William D. Figg
    Cancer Chemotherapy and Pharmacology, 1999, 43 : S78 - S84
  • [7] Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cells
    Dixon, SC
    Kruger, EA
    Bauer, KS
    Figg, WD
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (Suppl 1) : S78 - S84
  • [8] Location of prostate-specific membrane antigen in the LNCaP prostate carcinoma cell line
    Troyer, JK
    Beckett, ML
    Wright, GL
    PROSTATE, 1997, 30 (04): : 232 - 242
  • [9] Pharmacological uncoupling of androgen receptor-mediated prostate cancer cell proliferation and prostate-specific antigen secretion
    Sathya, G
    Chang, CY
    Kazmin, D
    Cook, CE
    McDonnell, DP
    CANCER RESEARCH, 2003, 63 (22) : 8029 - 8036
  • [10] Effects of Epilobium sp main constituents and ellagitannins metabolites, urolitins, on proliferation and prostate specific antigen (PSA) secretion in prostate cancer cells (lncap)
    Kiss, A. K.
    Granica, S.
    Piwowarski, J. P.
    PLANTA MEDICA, 2013, 79 (13) : 1216 - 1216